Beverley Wake

(Former)

View graph of relations

Recent publications

Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
Christopher Hyde, Beverley Wake, Stirling Bryan, Pelham Barton, Clare Davenport & Fujian Song, 1 Jan 2002, In: Health Technology Assessment. 6, 2, p. 1-89 89 p.

Research output: Contribution to journal › Article

Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's Lymphoma: a systematic review and economic evaluation
Beverley Wake, Christopher Hyde, Stirling Bryan, Pelham Barton, Fujian Song & Clare Davenport, 1 Jan 2002, In: Health Technology Assessment. 6, 3, p. 1-85 85 p.

Research output: Contribution to journal › Article

View all (2)